Sagimet Biosciences (SGMT) EPS (Basic) (2022 - 2026)
Sagimet Biosciences' (SGMT) quarterly EPS (Basic) came in at -$0.42 in Q1 2026, up 31.68% year-on-year from -$0.32 in Q1 2025, and down 2.69% quarter-over-quarter from -$0.41 in Q4 2025.
Sagimet Biosciences (SGMT) EPS (Basic) (2022 - 2026) Analysis & Trends
Sagimet Biosciences' EPS (Basic) history runs 5 years deep, the most recent figure standing at -$0.42 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 31.68% year-over-year to -$0.42 in Q1 2026; TTM through Mar 2026 was -$2.15, a 46.73% increase from a year earlier, with the FY2025 full-year figure at -$1.7, up 52.53% from the prior year.
- EPS (Basic) retreated to -$0.42 in Q1 2026 per SGMT's latest filing, from -$0.41 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.3 in Q1 2024 and bottomed at -$149.63 in Q2 2023.
- The 5-year median for EPS (Basic) is -$1.02 (2023), against an average of -$21.29.
- Across the five-year window, EPS (Basic) plunged 277.09% in 2023 and soared 99.78% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$60.63 in 2022, then surged by 89.59% to -$6.31 in 2023, then soared by 58.25% to -$2.63 in 2024, then jumped by 84.31% to -$0.41 in 2025, then decreased by 2.69% to -$0.42 in 2026.
- Per Business Quant, the three latest SGMT EPS (Basic) figures stand at -$0.42 (Q1 2026), -$0.41 (Q4 2025), and -$0.61 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Sagimet Biosciences | 227.27 Mn | 227.27 Mn | - | -0.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.42 |
| Dec 31, 2025 | -0.41 |
| Sep 30, 2025 | -0.61 |
| Jun 30, 2025 | -0.71 |
| Mar 31, 2025 | -0.62 |
| Dec 31, 2024 | -2.63 |
| Sep 30, 2024 | -0.51 |
| Jun 30, 2024 | -0.33 |
| Mar 31, 2024 | -0.30 |
| Dec 31, 2023 | -6.31 |
| Sep 30, 2023 | -1.32 |
| Jun 30, 2023 | -149.63 |
| Mar 31, 2023 | -36.16 |
| Dec 31, 2022 | -60.63 |
| Sep 30, 2022 | -40.35 |
| Jun 30, 2022 | -39.68 |